We sought to compare left ventricular (LV) function assessed with multislice computed tomography (MSCT), biplane cineventriculography (CVG), and transthoracic echocardiography (Echo), with magnetic resonance imaging (MRI) as the reference standard. BACKGROUND With the same data as acquired for noninvasive coronary angiography, MSCT enables registration of myocardial function.
To reliably evaluate global left ventricular (LV) function is of tremendous importance for determining the prognosis and therapeutic management in patients with known or suspected cardiac diseases (1) (2) (3) . Two-dimensional (2D) transthoracic echocardiography (Echo) is currently the clinically most widely used method but is operator-dependant and might be impaired by a poor acoustic window and inadequate endocardial border discrimination in 5% to 10% of patients (4, 5) . Contrast biplane cineventriculography (CVG) can also assess global function as part of cardiac catheterization (e.g., for coronary angiography) (6, 7) . The drawbacks of CVG include the fact that it uses a projectional method that makes certain geometrical assumptions (8) . Magnetic resonance imaging (MRI) is currently considered the reference standard for assessment of myocardial function (9, 10) . It now seems feasible to perform reliable noninvasive coronary angiography by using multislice computed tomography (MSCT) with at least 12 detector rows (11) (12) (13) (14) (15) (16) . It would be a clinically important advantage if the same data as acquired for noninvasive coronary angiography with MSCT could be also used to analyze LV function. Thus, we sought to compare the agreement and correlation of MSCT, CVG, and Echo with MRI as the reference standard for evaluation of global and regional LV function.
patients with suspected coronary artery disease who underwent a clinically indicated standardized in-house examination within 14 days of MRI. The clinical indications for Echo were angina pectoris (14 patients, 47%), shortness of breath (8 patients, 27%), arterial hypertension (6 patients, 20%), and pericardial effusion (2 patients, 7%). Magnetic resonance imaging served as the reference standard for comparison of MSCT, CVG, and Echo. The study group consisted of 64 men and 24 women (mean age 62 Ϯ 9 years). Patients with renal insufficiency (creatinine of at least 1.5 mg/dl), known allergy to iodinated contrast agents, hyperthyroidism, unstable angina pectoris, cardiac arrhythmia, pregnancy, contraindications to MRI (e.g., pacemaker), coronary artery stents, or bypass grafts were excluded. Seventeen patients were smokers, 45 patients had hyperlipidemia, and 61 patients had arterial hypertension. The study protocol was approved by the institutional review board; all patients gave written informed consent. Betablockers were not administered for any of the 4 modalities to avoid alteration of cardiac volumes for functional analysis. MRI. Magnetic resonance imaging was performed on a 1.5-T scanner (Magnetom Sonata, Siemens AG, Erlangen, Germany) equipped with a high-performance gradient subsystem (maximum amplitude ϭ 40 mT/m and a minimum rise time of 0.2 ms) with a 12-element phased-array coil optimized for cardiac imaging. For cardiac synchronization and monitoring, 3 electrodes of an active ECG system were placed on the patient's anterior hemithorax. Cinematic magnetic resonance images were acquired along the 2-and 4-chamber view and in the short-axis orientations with a segmented true fast imaging and steady precession (True-FISP) sequence with asymmetric sampling of echoes with the following parameters: repetition time ϭ 2.8 ms, echo time ϭ 1.2 ms, slice thickness ϭ 8 mm, no interslice gap, voxel size ϭ 1.7 ϫ 1.3 ϫ 8 mm, acquisition window/phase ϭ 34 ms (24 segments/phase), slice resolution ϭ 100%, and flip angle ϭ 54°. We chose a length of 34 ms for 1 phase, because the temporal resolution should be between 20 and 40 ms to allow accurate assessment of myocardial function with MRI (17) . Parallel imaging (generalized autocalibrating partially parallel acquisitions) with an acceleration factor of 2 was employed (18) . Two slices along the cardiac short-axis were acquired within 1 breath hold of 14 heartbeats, and the entire heart was covered from base to apex without gaps. Analysis of the global LV function parameters was performed by 1 reader blinded to the results of MSCT, CVG, and Echo with the short-axis slices with ARGUS according to Simpson's rule (Version 2002B, Siemens). For assessment of myocardial mass, the papillary muscles were assigned to the LV muscle (19, 20) . Basal slices with Ͻ180°c ircumferential LV muscle ring at end-systole were excluded from analysis as described recently (21) . Regional LV function was assessed with a 4-point scale (1, normal; 2, hypokinesia; 3, akinesia; 4, dyskinesia) (22) for all 17 myocardial segments according to the American Heart Association (AHA) segmentation in each patient (23) .
MSCT. Multislice computed tomography was performed during 1 breath hold on a 16-slice CT scanner (Aquilion, Toshiba, Otawara, Japan) with 400 ms gantry rotation time, 16 ϫ 0.5 mm detector collimation, 0.35 ϫ 0.35 mm 2 pixel size (10 line pairs/cm), 120 kV, 300 mA, and 0.2 pitch. The effective dose was estimated with CT-Expo Version 1.3 (24) . A nonionic contrast agent (iodixanol, visipaque 320, 320 mg I/ml, GE-Healthcare Biosciences, Buckinghamshire, United Kingdom) was injected intravenously at a speed of 3.5 ml/s. The manual sure-start feature of the scanner was used to visualize the influx of the contrast medium (bolus-tracking) and to start image acquisition. Images were reconstructed with the multisegment approach (25) correlated with the raw data from up to 4 heartbeats (12) at 10 time points at 10% intervals with the center of the reconstruction window being between 0% and 90% of the cardiac cycle as described recently (26) . The major determinant of image quality in cardiac MSCT is temporal resolution, which is defined by the image acquisition window. It was recently shown that cardiac function can be accurately assessed by MSCT with multisegment reconstruction without the need to alter heart rates by administration of Dewey et al. November 21, 2006 November 21, :2034 CT Evaluation of LV Function beta-blockers (25) . Thus, no beta-blockers were administered for MSCT and the other 3 functional modalities. The images reconstructed at the equidistant time points within the cardiac cycle enabled us to derive functional information from the MSCT data on the scanner's workstation with true contiguous 8-mm short-axis orientations and the volume method of the scanner's semi-automatic cardiac function analysis software as described (26) . This volumetric approach allowed choosing the end-diastolic and end-systolic time points according to the LV volumes for all 10 time points. As with MRI, the automatically generated endocardial contours excluded the papillary muscles (26) . In this way, 1 reader blinded to the results of MRI, CVG, and Echo calculated LV volumes according to Simpson's rule. Basal slices with Ͻ180°circumferential LV muscle ring at end-systole were excluded from analysis as described recently (21) . Regional LV function was also assessed with the short-axis orientations and 2-and 4-chamber views with the 4-point scale for all 17 myocardial segments in each patient. Intraobserver variability for assessment of global and regional function with MSCT was evaluated for 29 randomly chosen data sets after a time delay of at least 6 months after the first reading. CVG. Selective X-ray cineventriculography was performed with standard techniques with a frame rate of 30/s. Forty to 50 ml of a nonionic contrast agent was injected into the LV with a flow rate of 10 to 12 ml/s with a 5-F or 7-F pigtail catheter. An interventional cardiologist who was unaware of the MRI, MSCT, and Echo results analyzed LV function (Integris 3000, Philips Medical Systems, Bothel, Washington) on 2 orthogonal projections (30°right anterior oblique and 60°left anterior oblique) with the area-length method (8, 27 ) and metallic spheres as calibration devices. In this way, absolute LV function values could be determined besides the ejection fraction. Regional LV function was also assessed with the 4-point scale for all 17 myocardial segments in each patient. (9), and a 1-sample t test was used to analyze whether the mean differences from 0 (systematic under-estimation or overestimation of results) of MSCT, CVG, and Echo in comparison with MRI were significantly different from each other. Intraobserver variability for assessment of global function with MSCT was evaluated for 29 randomly chosen data sets by 1 reader after a time delay of at least 6 months after the first reading and was also analyzed with the limits of agreement (1.96 ϫ SD ϭ 95% CIs) determined with Bland-Altman analysis (29) . The results of MRI served as the reference standard for assessing the sensitivity, specificity, accuracy, and negative and positive predictive values of MSCT, CVG, and Echo for detection of regional wall motion abnormalities in an intention-to-diagnose design (no patients or segments were excluded from analysis owing to inadequate image quality) (30 
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with a higher correlation and slope for MSCT, whereas the intercepts (differences of the regression line from 0 on the y-axis) were larger for CVG and Echo (Tables 1 and  2 ). In Bland-Altman analysis, the limits of agreement (95% CIs) for MSCT were significantly smaller than for CVG (Ϯ 10.2% vs. Ϯ 16.8%; p Ͻ 0.001 with the F test) and Echo (Ϯ 11.0% vs. Ϯ 21.2%; p Ͻ 0.001 with the F test) (Fig. 1) . LV end-diastolic and end-systolic volume. The enddiastolic and end-systolic volumes showed significant correlations (p Ͻ 0.001) for the comparisons of MSCT, CVG, and Echo with MRI, again with larger intercepts for CVG and Echo (Tables 1 and 2 ). In Bland-Altman analysis, there were significantly larger limits of agreement for CVG (Ϯ 66.7 ml) than for MSCT (Ϯ 40.5 ml; p Ͻ 0.001) and there was also a significantly larger overestimation of the end-diastolic volume with CVG (80 ml) than with MSCT (6.2 ml; p Ͻ 0.001 with the t test; Figs. 2A and 2B ). In Bland-Altman analysis, the limits of agreement for MSCT were significantly smaller than for Echo (Ϯ 47.8 ml vs. Ϯ 95.8 ml; p Ͻ 0.001 with the F test) (Figs. 2C and 2D ).
Bland-Altman analysis also demonstrated significantly larger limits of agreement for the assessment of end-systolic volume with Echo (Ϯ 51.2 ml) than with MSCT (Ϯ 32.1 ml; p Ͻ 0.02 with the F test) (Figs. 3C and 3D ). There were also significantly larger limits of agreement for end-systolic volume with CVG (Ϯ 36.4 ml) than with MSCT (Ϯ 25.3 ml; p Ͻ 0.001 with the F test) (Figs. 3A and 3B ). The mean of the differences of end-systolic volume in Bland-Altman analysis had a significantly larger deviation from 0 for CVG (Fig. 4) . Linear regression analysis revealed significant linear correlations, a slope of 0.89, and an r value of 0.93 for this comparison (p Ͻ 0.001) ( Table 1) . Intraobserver variability. For the 29 randomly selected patients who had intraobserver variability of MSCT analyzed after an interval of at least 6 months, the limits of agreement for ejection fraction, end-diastolic volume, endsystolic volume, and myocardial mass were Ϯ 4.8%, Ϯ 15.6 ml, Ϯ 8.0 ml, and Ϯ 18.2 g, respectively, demonstrating a low variability for MSCT (Figs. 4 and 5) . Per-patient regional function. Magnetic resonance imaging demonstrated at least 1 myocardial segment with a wall motion deficit in 34 of the 88 patients. An example of a regional wall motion abnormality as detected with all 4 diagnostic methods is shown in Figure 6 (see the Appendix for supplementary video files). Of the 493 myocardial segments (in 29 patients) analyzed a second time with MSCT, 96.8% (477 segments) were assigned to the same category on the 4-point scale as during the first analysis, the pairwise McNemar's test showed no significant differences between the assessments, and Cohen's kappa was 0.82, indicating good assessment agreement with MSCT also in the persegment analysis.
DISCUSSION
Multislice computed tomography is an emerging modality for the noninvasive assessment of cardiac anatomy and function. This study showed for the first time that the evaluation of global and regional LV function with MSCT is more accurate than CVG in comparison with MRI as the reference standard. There was no significant difference of MSCT with Echo in identifying patients with abnormal regional function, whereas the agreement for assessment of ejection fraction and end-diastolic and end-systolic volume was significantly superior with MSCT. The variability of MSCT in determining global and regional LV function was proven to be sufficiently small for clinical application. Given that accurate noninvasive coronary angiography has become feasible with MSCT with at least 12 detector rows (11) (12) (13) (14) (15) (16) , the results of the present study have relevant clinical implications because it has become possible to perform a combined assessment of the coronary arteries and LV function noninvasively with the same data acquired within a single breath hold MSCT examination. Comparison with previous studies. The LV ejection fraction that could be assessed with CVG compared with MRI with limits of agreement (Ϯ 17%) comparable to those reported in previous studies (Ϯ 19% [9] and Ϯ 24% [32] ). However, from previous head-to-head comparisons with MRI, it is well known that end-diastolic and end-systolic volumes are systematically overestimated by cineventriculography (9, 27, 33) as a result of geometric assumptions (8) and the angiographic magnification error (34) . These observations were confirmed by the present study. Moreover, the assessment of regional LV function was more accurate with the cross-sectional modality MSCT than with CVG, which can be explained by the projectional nature of the CVG data. For this reason, CVG is especially limited in the detection of lateral and septal wall motion abnormalities as shown in a comparison of CVG with Echo as another cross-sectional imaging modality (35) . (21,36 -39) . Thus, MSCT might be used as an alternative in patients with a poor acoustic window in Echo or contraindications to MRI for evaluating global and regional LV function or in combination with noninvasive coronary angiography. The agreement of MSCT with MRI in evaluating global and regional LV function might be further improved with shorter gantry rotation times. The average length of the image acquisition window/heartbeat achieved in the present study (148 ms) is considerably shorter than the one achieved in a previous study (208 ms) (21) . Nevertheless, MSCT is still far from the temporal resolution that is necessary for optimal detection of the end-systolic period (length of the image acquisition window of about 20 to 50 ms) (17, 40) .
Regarding intraobserver variability, the limits of agreement of MSCT for ejection fraction, end-diastolic volume, and end-systolic volume (Ϯ 4.8%, Ϯ 15.6 ml, Ϯ 8.0 ml, respectively) are comparable to those reported by Buck et al. (9) for three-dimensional (3D) Echo (Ϯ 5.4%, Ϯ 12.4 ml, Ϯ 7.8 ml, respectively). Kühl et al. (41) recently reported slightly larger intraobserver limits of agreement for ejection fraction with real-time 3D Echo with a semi-automatic analysis tool (Ϯ 8.2%). The intraobserver variability for end-diastolic and end-systolic volumes with MRI is slightly ) on the basis of 6 subjects with limits of agreement of Ϯ 7.6 ml and Ϯ 4.6 ml, respectively. Contrast and noncontrast 2D Echo were recently shown to have sufficiently small limits of agreement for ejection fraction in intraobserver analysis of Ϯ 2.6% and 9.4%, respectively (4). Moreover, interobserver variability can also be significantly reduced with contrast administration for Echo (42) . Intraobserver agreement for per-patient and per-segment regional function was sufficiently high in our study (90% and 96.8%, respectively) to allow reliable evaluation with MSCT. Nowadays, Echo is the most widely used technique for evaluating LV function. In routine use, Echo offers some important advantages when compared with the other diagnostic tests: it can be easily performed at the bedside as a rapid screening tool, does not expose the patients to radiation, and it is inexpensive. Noncontrast 2D Echo in comparison with MRI has been reported in a multicenter trial involving 55 patients to be fairly accurate for assessment of ejection fraction with limits of agreement of Ϯ 21.6% (42) . These values are in the same range as in our study for the comparison of MRI and Echo (Ϯ 21.2%). With contrast application, the limits of agreement of 2D Echo for ejection fraction can be reduced to Ϯ 17.4% (42) , whereas MSCT has demonstrated in the present study limits of agreement of Ϯ 10.2%. Study limitations. The present study is, to our best knowledge, the first head-to-head comparison of MSCT, CVG, and Echo with MRI as the reference standard, but it had limitations. All patients included had suspected coronary artery disease, and the majority of the patients had a global cardiac function in a normal range (16 patients had myocardial infarction, 23 patients had an ejection fraction of Ͻ60% on MRI). Therefore, results of the study cannot be generalized to all cardiac patients, especially those with chronic myocardial infarction and remodeled ventricles.
However, consecutive patients were included, and the results are valid for the comparison of MRI, MSCT, CVG, and Echo in patients with suspected coronary artery disease. We did not compare MSCT of global and regional function with 3D Echo or contrast 2D Echo, which has been shown to improve assessment (9, 42, 43) , but with CVG, 2D Echo, and MRI. Echo was only performed in a subset of 30 patients. With standard halfscan reconstruction, the average length of the image acquisition window is 30% of the R-R interval, whereas with multisegment reconstruction this length, which defines the temporal resolution, can be improved to 17% of the R-R interval (25) . Given this temporal resolution of MSCT, it becomes obvious that there is no benefit to be expected from more than 10 reconstruction time points within each R-R interval because, with 10 reconstructions, each of them covers a relative proportion of 10% of the R-R interval, which is already better than the actual temporal resolution. We did not systematically analyze the end-diastolic and end-systolic time points. An advantage over previous studies is that patients with a variety of heart rates and no administration of beta-blockers and thus unaltered ventricular function were examined. Conclusions. It should not be forgotten that MSCT involves radiation exposure and use of an iodinated contrast agent. Therefore, we believe that MSCT might be used for assessment of LV function in patients with a poor acoustic window in Echo or contraindications to MRI. In case of a clinical indication for noninvasive coronary angiography with MSCT, valid data regarding global and regional LV function can be obtained without additional radiation exposure or contrast agent administration. The assessment of global and regional LV function with MSCT is more accurate than with CVG in comparison with MRI, whereas MSCT is superior to Echo only in the evaluation of global function. Figure 6 . Example of a 48-year-old male patient with akinesia of the posterolateral wall on MRI (first column, short-axis view), MSCT (second column, short-axis view), CVG (third column, left anterior oblique view), and Echo (last column, short-axis view). Abbreviations as in Figure 1 .
